"The federal government is not planning any further investments in companies that are researching a Covid-19 vaccine," says a response from the federal government to a request from the Greens, about which the "Handelsblatt" (Tuesday edition) reports. "Other companies have not asked the federal government," the answer goes on.
CureVac has been researching a corona vaccine since January. In mid-June, the federal government acquired a stake of around 300 percent in the Tübingen vaccine developer for 23 million euros. The federal participation is intended to ensure that the company is not taken over by a foreign investor and moves abroad. The federal government's entry into CureVac had caused controversy. Greens finance politician Daniel Bayaz criticizes: “The participation was surprising, hasty and non-transparent. Such decisions should at least be discussed in the Bundestag. ”